{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:35:20Z","timestamp":1773221720548,"version":"3.50.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/jac\/dki451","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T01:25:14Z","timestamp":1134609914000},"page":"367-368","source":"Crossref","is-referenced-by-count":42,"title":["Activity of mecillinam against ESBL producers in vitro"],"prefix":"10.1093","volume":"57","author":[{"given":"K.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Weinbren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Livermore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,14]]},"reference":[{"key":"key\n\t\t\t\t20171010194150_B1","doi-asserted-by":"crossref","unstructured":"Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother2005; 56: 451\u20134.","DOI":"10.1093\/jac\/dki239"},{"key":"key\n\t\t\t\t20171010194150_B2","doi-asserted-by":"crossref","unstructured":"Paterson DL, Ko WC, Von Gottberg A et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol2001; 39: 2206\u201312.","DOI":"10.1128\/JCM.39.6.2206-2212.2001"},{"key":"key\n\t\t\t\t20171010194150_B3","doi-asserted-by":"crossref","unstructured":"Andrews JM. BSAC standardized disc susceptibility testing method (version 4). J Antimicrob Chemother2005; 56: 60\u201376.","DOI":"10.1093\/jac\/dki124"},{"key":"key\n\t\t\t\t20171010194150_B4","doi-asserted-by":"crossref","unstructured":"Carter MW, Oakton KJ, Warner M et al. Detection of extended-spectrum \u03b2-lactamases in klebsiellae with the Oxoid combination disk method. J Clin Microbiol2000; 38: 4228\u201332.","DOI":"10.1128\/JCM.38.11.4228-4232.2000"},{"key":"key\n\t\t\t\t20171010194150_B5","doi-asserted-by":"crossref","unstructured":"Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother2000; 46 Suppl 1: 35\u20139.","DOI":"10.1093\/jac\/46.suppl_1.35"},{"key":"key\n\t\t\t\t20171010194150_B6","doi-asserted-by":"crossref","unstructured":"Graninger W. Pivmecillinam\u2014therapy of choice for lower urinary tract infection. Int J Antimicrob Agents2003; 22 Suppl 2: 73\u20138.","DOI":"10.1016\/S0924-8579(03)00235-8"},{"key":"key\n\t\t\t\t20171010194150_B7","unstructured":"Antipov AV. Chemotherapeutic effectiveness of mecillinam and dioxidine in an experiment using polyresistant Escherichia coli. Antibiot Med Biotekhnol1987; 32: 683\u20135."},{"key":"key\n\t\t\t\t20171010194150_B8","doi-asserted-by":"crossref","unstructured":"Moosdeen F, Williams JD, Yamabe S. Antibacterial characteristics of YTR 830, a sulfone \u03b2-lactamase inhibitor, compared with those of clavulanic acid and sulbactam. Antimicrob Agents Chemother1988;32: 925\u20137.","DOI":"10.1128\/AAC.32.6.925"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/2\/367\/2407885\/dki451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T15:50:21Z","timestamp":1586620221000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/2\/367\/804696\/Activity-of-mecillinam-against-ESBL-producers-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,14]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,14]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki451","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,14]]}}}